HealthAugust 25, 2022

DEA expectations and best practices: How to investigate and report suspected drug diversion in your healthcare facility

The Drug Enforcement Administration (DEA) expects healthcare facilities to have robust policies and procedures in place to prevent and address drug diversion. Best practices for investigating and reporting suspected drug diversion include conducting thorough investigations, involving law enforcement when necessary, and implementing measures to prevent future incidents.

This educational webinar presented by Dwayne Jeffcoat, DEA Diversion Investigator discusses drug diversion cases that have resulted in record fines.

Key takeaways from the DEA on suspected diversion

  • The DEA’s expectations on how you should investigate suspected diversion in your healthcare facility, including how to collect and retain evidence, compile your investigation notes, and document the results of your investigation.
  • Your responsibilities for reporting suspected diversion, such as submitting DEA Form 106.
  • What your healthcare facility should compile for the “investigation file” that could later be provided to the DEA when the DEA arrives to conduct its investigation.
  • Real examples of how you can set yourself and your team up to prevent diversion and be in compliance with DEA regulations for investigating and reporting diversion in your hospital or healthcare facility

Watch the webinar to learn more

Drug Diversion
Quickly uncover potential diversion from purchase to patient with predictive analytics and actionable dashboards.
Reconciles drug transactions using AI to rapidly and accurately identify patterns of behavior consistent with drug diversion.
Back To Top